Abstract Details

Title Evaluating FDA Bioequivalence Standards for Generic Carbamazepine Formulations

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 085

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Gregory Krauss, MD (Johns Hopkins University)	Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
	No disclosure on file
	No disclosure on file

��ɫ����